Charge reversal Pulullan derivative and synthesis method and application thereof

A technology of pullulan polysaccharide and charge reversal, which is applied in the field of charge reversal pullulan polysaccharide derivatives and their synthesis, which can solve the problems of in vivo application limitations, lack of tumor targeting, etc., and achieve simple synthesis process and no immunogenicity , the effect of improving stability

Inactive Publication Date: 2016-05-11
TIANJIN MEDICAL UNIV
View PDF5 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these positively charged carrier systems have biological safety and stability problems (such as hemolysis, e...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Charge reversal Pulullan derivative and synthesis method and application thereof
  • Charge reversal Pulullan derivative and synthesis method and application thereof
  • Charge reversal Pulullan derivative and synthesis method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] 1. Synthesis of diethylenetriamine-modified pullulan (AMPL) (e.g. figure 1 )

[0049] Dissolve 500mg of pullulan (molecular weight 200kDa) and 500mg of N,N'-carbonyldiimidazole (CDI) in 20ml of anhydrous dimethylsulfoxide (DMSO) and stir for 5-10min, then slowly at a speed of 1-2ml / min Drop into 10ml of DMSO solution dissolved with 2ml of diethylenetriamine, and stir at 35°C for 20h. After the reaction, the reaction solution was transferred to a dialysis bag (molecular weight cut-off 12-14kDa), dialyzed in ultrapure water for 3 days, and the dialysate was freeze-dried for 40 hours. The white flocculent product obtained was AMPL. The degree of substitution of the polyamino-modified group can be calculated by detecting the content of nitrogen element by means of elemental analysis, which is 15.7%.

[0050] 2. Synthesis of cis-4-cyclohexene-1,2-dicarboxylic acid monoamidation-diethylenetriamine-modified pullulan (CAPL) (e.g. figure 1 ).

[0051] Dissolve 200mg of the...

Embodiment 2

[0075] 1. Synthesis of spermine-modified pullulan (SPL)

[0076] Dissolve 500mg of pullulan (molecular weight 200kDa) and 500mg of N,N'-carbonyldiimidazole (CDI) in 20ml of anhydrous dimethylsulfoxide (DMSO) and stir for 5-10min, then slowly at a speed of 1-2ml / min Drop into 10ml of DMSO solution dissolved with 5ml of spermine, and stir at 35°C for 24h. After the reaction, the reaction solution was transferred to a dialysis bag (molecular weight cut-off 12-14kDa), dialyzed in ultrapure water for 3 days, and the dialysate was freeze-dried for 40 hours. The obtained white flocculent product was SPL. The degree of substitution of the spermine-modified group was 37.9%.

[0077] 2. Synthesis of maleic acid monoacylation-spermine modified pullulan (MSPL)

[0078] Dissolve 200 mg of the above SPL in 10 ml of DMSO, add 100 mg of maleic anhydride and stir for 24 hours, then pour the reaction solution into cold ethanol solution, a white flocculent precipitate is precipitated, collec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Molecular massaaaaaaaaaa
Login to view more

Abstract

The invention relates to a charge reversal Pulullan derivative and a synthesis method and application thereof. The Pulullan derivative is composed of a Pulullan framework, a multi-amino modified group and a beta-carboxylic acid amide modified group, has remarkable liver/liver cancer targeting property, and can quickly respond to a faintly acid tumor microenvironment and a cell endosome/lysosome so as to achieve reversal from electronegativity to electropositivity. By modifying poly(beta-amino ester) (PBAE)/polylactic acid-polyglycolic acid copolymer (PLGA) composite nanoparticles with the Pulullan derivative, liver cancer targeted delivery of nanoparticles can be mediated efficiently, effective release of a carried drug at the tumor position is achieved, and the charge reversal Pulullan derivative is a liver/liver cancer targeted carrier material with excellent performance for drugs, genes and image contract agents and has broad application space.

Description

technical field [0001] The invention relates to a charge-reversal pullulan derivative and its synthesis method and application. Specifically, it is prepared by modifying pullulan with polyamino compounds, and introducing pH-sensitive β-carboxylic acid amide bonds through the reaction of terminal amino groups with phthalic anhydrides. Pullulan derivatives have liver / liver cancer targeting properties, can quickly respond to the weakly acidic tumor microenvironment and cell endosomes / lysosomes, and realize the reversal from negative to positive, and can be used as drugs, genes The invention relates to a liver / liver cancer targeting carrier material of an imaging contrast agent, belonging to the technical field of biochemical medicine. Background technique [0002] Biomedical polymer materials are an important part of biomaterials, and have been widely used in the field of medicine, such as diagnosis and treatment of diseases, replacement or repair of damaged tissues and organs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C08B37/02A61K47/36A61K9/14A61K49/00A61P35/00A61P1/16
CPCA61K9/145A61K47/36A61K49/00C08B37/0018
Inventor 王银松张聪安彤王丹
Owner TIANJIN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap